Sanofi 2Q: Dupixent's First Set Of Sales Are On Track

 
• By Lucie Ellis-Taitt
Railway
Sanofi's newly launched eczema drug Dupixent is on track after a solid quarter • Source: Shutterstock

More from Earnings

More from Business